Goldman Sachs’s Science Strategic Acquisition Corp. Alpha Class A Common Stock SSAA Stock Holding History

Goldman Sachs’s Portfolio SSAA Stock Details SSAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-25,007	Closed	-$247K	–	6512
2022 Q3	$247K	Sell	25,007 -233,470	-90%	-$2.3M	﹤0.01%	5387
2022 Q2	$2.54M	Hold	258,477	–	–	﹤0.01%	3841
2022 Q1	$2.54M	Buy	258,477 +25,000	+11%	+$244K	﹤0.01%	4023
2021 Q4	$2.28M	Hold	233,477	–	–	﹤0.01%	4151
2021 Q3	$2.27M	Sell	233,477 -2,800	-1%	-$27.2K	﹤0.01%	4080
2021 Q2	$2.29M	Buy	236,277 +25,497	+12%	+$249K	﹤0.01%	4082
2021 Q1	$2.03M	Buy	+210,780	New	+$2.06M	﹤0.01%	3970

Goldman Sachs's SSAA Position: Q4 2022 in Review

Goldman Sachs sold out of Science Strategic Acquisition Corp. Alpha Class A Common Stock (SSAA) in Q4 2022, closing a stake of 25,007 shares — an estimated $247K sold.

Goldman Sachs first reported a position in SSAA in Q1 2021 and held it in 7 quarters. The position peaked at $2.54M in Q2 2022. 0 funds tracked by Wall St. Rank hold SSAA as of Q4 2022.

Goldman Sachs reported no remaining Science Strategic Acquisition Corp. Alpha Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Goldman Sachs sold 25,007 Science Strategic Acquisition Corp. Alpha Class A Common Stock shares in Q4 2022, an estimated $247K.
Goldman Sachs first reported a position in Science Strategic Acquisition Corp. Alpha Class A Common Stock in Q1 2021 and held it in 7 quarters.
Goldman Sachs's Science Strategic Acquisition Corp. Alpha Class A Common Stock position peaked at $2.54M in Q2 2022.
0 funds tracked by Wall St. Rank held Science Strategic Acquisition Corp. Alpha Class A Common Stock as of Q4 2022.

Based on Goldman Sachs's 13F filing for Q4 2022, filed 13 Feb 2023.